Labetalol
Combined alpha and beta-blocker for hypertensive emergencies and perioperative blood pressure control.
Product Overview
Labetalol hydrochloride injection is a combined alpha and beta-adrenergic blocker used for acute blood pressure management. It provides smooth, controlled reduction in blood pressure without reflex tachycardia.
| Specification | Details |
|---|---|
| Product Name | Labetalol 5 mg/mL |
| Concentration | 5 mg/mL |
| Fill Volume | 4 mL (20 mg total) |
| Container | Single-Dose Vial (SDV) |
| Beyond Use Dating | 12 months |
| Storage | Controlled room temperature |
Related Articles
January 10, 2026
Medivant Healthcare Partners with Angels for Change to Address Drug Shortages
Medivant Healthcare announces its partnership with Angels for Change and the upcoming launch of Lorazepam injectable vials to help address critical drug shortages.
Read More
June 1, 2025
Medivant Healthcare: Scalable cGMP Sterile Injectable Manufacturing
Medivant Healthcare highlights its scalable, fully automated cGMP sterile injectable manufacturing capabilities designed to improve supply chain reliability and meet growing healthcare demand.
Read More
June 10, 2024
Medivant Healthcare at Health Connect Partners Pharmacy Show in Indianapolis
Medivant Healthcare participated in the Health Connect Partners pharmacy show in Indianapolis, connecting with attendees and showcasing solutions for sterile injectable shortages.
Read MoreRequest Product Information
Contact our team for specifications, pricing, and availability.